Physician

Jennifer L. Ball, DO

According to 2025 Medicare claims, Jennifer Ball, DO (NPI: 1386635548) practices hematology/oncology in the St. Petersburg-Clearwater-Largo, FL market, with the plurality of this provider's patient population coming from Pinellas, FL. This provider's primary affiliated billing organization is FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (NPI: 1760590962; TIN: 65-0825133) and primary practice location at 33761-2029.

Ball's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,021 traditional Medicare patients, billed 420,606 HCPCS/CPT codes, and received $4,489,707 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,240 prescription claims across 438 beneficiaries totaling $5,021,937 in drug costs, led by Revlimid (Lenalidomide). DME data shows 18 claims. Open Payments data shows 21 records totaling $473. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $2,697,579 and ending at $4,489,707. Concurrently, Part D prescription costs have risen steadily, from $1,341,488 to $5,021,937. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	936	278,026	$2,697,579
2016	964	357,273	$2,673,443
2017	1,044	375,291	$2,947,951
2018	1,085	434,617	$3,377,935
2019	1,247	556,562	$4,028,908
2020	912	448,433	$2,960,013
2021	817	487,808	$3,255,298
2022	881	347,409	$2,520,569
2023	1,147	494,408	$3,970,497
2024	1,021	420,606	$4,489,707

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	297	1,683	$1,341,488
2016	309	1,848	$2,061,723
2017	332	1,862	$2,316,553
2018	330	1,857	$3,473,803
2019	305	1,821	$3,230,307
2020	254	1,637	$2,986,706
2021	278	1,774	$2,950,706
2022	336	1,728	$3,471,609
2023	480	2,524	$4,214,565
2024	438	2,240	$5,021,937

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	133	$47,516
2016	N/R	123	$35,893
2017	11	103	$22,414
2018	12	68	$12,351
2019	N/R	64	$9,623
2020	12	74	$11,169
2021	N/R	28	$8,577
2022	N/R	21	$1,898
2023	13	86	$12,665
2024	12	18	$2,223

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	339	996	$94
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	564	1,040	$64
96372	Injection of drug or substance under skin or into muscle	335	1,436	$11
36415	Insertion of needle into vein for collection of blood sample	750	2,331	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	777	2,839	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	90	2,511	$1,529,607
Calquence	Acalabrutinib Maleate	43	1,290	$653,573
Jakafi	Ruxolitinib Phosphate	31	918	$482,710
Brukinsa	Zanubrutinib	27	810	$393,826
Imbruvica	Ibrutinib	20	560	$393,819

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	12	18	$2,223

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$473	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jennifer L. Ball, DO?

Tedicare shows public-source Medicare data for Jennifer L. Ball, DO (NPI 1386635548), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jennifer L. Ball, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jennifer L. Ball, DO?

Jennifer L. Ball, DO is linked to FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (billing NPI 1760590962) in the available physician profile data.

Does Jennifer L. Ball, DO have Open Payments data?

Jennifer L. Ball, DO has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.